Quote | Sigyn Therapeutics Inc (OTCMKTS:SIGY)
Last: | $5.75 |
---|---|
Change Percent: | 0.0% |
Open: | $5.75 |
Close: | $5.75 |
High: | $5.75 |
Low: | $5.75 |
Volume: | 256 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Sigyn Therapeutics Inc (OTCMKTS:SIGY)
Sigyn Therapeutics (OTCQB: SIGY) , a medical technology that creates medical solutions to treat life-threatening conditions, is developing a portfolio of technologies, including Sigyn Therapy(TM), ChemoPrep(TM), ChemoPure(TM) and ImmunePrep(TM), which have each been designed to overcome a current...
Sigyn Therapeutics (OTCQB: SIGY) , a medical technology company, is developing blood purification technologies to treat life-threatening conditions that are not addressed with current market-cleared drug agents as well as an expansive pipeline of technologies to optimize the benefit of cancer the...
Message Board Posts | Sigyn Therapeutics Inc (OTCMKTS:SIGY)
Subject | By | Source | When |
---|---|---|---|
seems a pump might be coming, unless it's | rhopton | investorshub | 03/10/2023 12:27:04 PM |
no idea I just saw it when you | PennyStockTrader2 | investorshub | 03/10/2023 12:22:31 PM |
what happened yesterday, more volume than the last | rhopton | investorshub | 03/10/2023 11:18:29 AM |
talk about dead money this has been, very | PennyStockTrader2 | investorshub | 01/09/2023 4:38:53 PM |
Sigyn Therapeutics - $SIGY Featured in PubCoInsight. | FinlayS00 | investorshub | 06/22/2022 6:44:57 PM |
News, Short Squeeze, Breakout and More Instantly...
Sigyn Therapeutics Inc Company Name:
SIGY Stock Symbol:
OTCMKTS Market:
Sigyn Therapeutics (OTCQB: SIGY) , a medical technology that creates medical solutions to treat life-threatening conditions, is developing a portfolio of technologies, including Sigyn Therapy(TM), ChemoPrep(TM), ChemoPure(TM) and ImmunePrep(TM), which have each been designed to overcome a current...
Sigyn Therapeutics (OTCQB: SIGY) , a medical technology company, is developing blood purification technologies to treat life-threatening conditions that are not addressed with current market-cleared drug agents as well as an expansive pipeline of technologies to optimize the benefit of cancer the...
Sigyn Therapeutics (OTCQB: SIGY) , a development-stage medical technology company, recently expanded its therapeutic candidates, introducing ImmunePrep(TM) to improve the delivery of immunotherapeutic antibodies to treat cancer. “The company is also developing ChemoPrep(TM) and ChemoP...